Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism
Open Access
- 1 December 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 128 (8) , 1795-1803
- https://doi.org/10.1038/sj.bjp.0702978
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997
- Effect of an Endothelin Antagonist on Hemodynamic Responses to Angiotensin IIHypertension, 1996
- Paracrine regulation of the renal microcirculationPhysiological Reviews, 1996
- Endothelin in the Kidney in Malignant Phase HypertensionHypertension, 1995
- Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive ratsBritish Journal of Pharmacology, 1995
- Heterogeneity in Vascular Smooth Muscle Responsiveness to Angiotensin IIHypertension, 1995
- Nitric Oxide Synthase Blockade and Renal Vascular Responses to Norepinephrine and Endothelin-1 in Conscious DogsJournal of Cardiovascular Pharmacology, 1995
- In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670British Journal of Pharmacology, 1995
- Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2General Pharmacology: The Vascular System, 1994
- Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 geneAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1994